Procter & Gamble Health Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 342.77 | 314.10 | 313.73 |
| Operating Expense | 248.40 | 230.07 | 186.34 |
| Net Profit | 66.18 | 61.18 | 90.90 |
| Net Profit Margin | 19.31 | 19.48 | 28.97 |
| Earning Per Share | 39.87 | 36.86 | 54.76 |
| EBIDTA | 94.68 | 87.39 | 125.64 |
| Effective Tax Rate | 24.31 | 24.65 | 22.80 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 342.77 |
| Operating Expense | 248.40 |
| Net Profit | 66.18 |
| Net Profit Margin | 19.31 |
| Earning Per Share | 39.87 |
| EBIDTA | 94.68 |
| Effective Tax Rate | 24.31 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Jun 2024 | Jun 2023 |
|---|---|---|---|
| Total Revenue Annual | 934.17 | 1,151.26 | 1,229.62 |
| Operating Expenses Annual | 615.78 | 845.26 | 904.94 |
| Operating Profit Annual | 328.74 | 301.44 | 343.07 |
| Interest Annual | 0.43 | 0.72 | 0.77 |
| Depreciation | 16.69 | 27.40 | 28.10 |
| Net Profit Annual | 234.41 | 200.98 | 229.47 |
| Tax Annual | 77.21 | 72.34 | 84.73 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 934.17 |
| Operating Expenses Annual | 615.78 |
| Operating Profit Annual | 328.74 |
| Interest Annual | 0.43 |
| Depreciation | 16.69 |
| Net Profit Annual | 234.41 |
| Tax Annual | 77.21 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Jun 2024 | Jun 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 238.73 | 435.42 | 319.40 |
| Cash Flow from Operations | 168.69 | 228.29 | 236.01 |
| Cash Flow from Investing | 9.59 | -6.87 | -21.50 |
| Cash Flow from Financing | -234.74 | -418.11 | -98.49 |
| Cash Flow at the End | 182.27 | 238.73 | 435.42 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 238.73 |
| Cash Flow from Operations | 168.69 |
| Cash Flow from Investing | 9.59 |
| Cash Flow from Financing | -234.74 |
| Cash Flow at the End | 182.27 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Jun 2024 | Jun 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 35.19 | 26.18 | 27.90 |
| PBIT Margin (%) | 33.40 | 23.80 | 25.62 |
| PBT Margin (%) | -44.28 | -9.26 | -7.65 |
| Net PROFIT Margin (%) | 25.09 | 17.46 | 18.66 |
| Return On Networth / Equity (%) | 32.74 | 31.18 | 33.56 |
| Return On Networth /Employed (%) | 40.23 | 39.76 | 43.16 |
| Return On Assets (%) | 30.11 | 29.15 | 31.54 |
| Total Debt / Equity (X) | 0.01 | 0.02 | 0.01 |
| Asset Turnover Ratio (%) | 1.20 | 1.67 | 1.69 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 35.19 |
| PBIT Margin (%) | 33.40 |
| PBT Margin (%) | -44.28 |
| Net PROFIT Margin (%) | 25.09 |
| Return On Networth / Equity (%) | 32.74 |
| Return On Networth /Employed (%) | 40.23 |
| Return On Assets (%) | 30.11 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 1.20 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Jun 2024 | Jun 2023 |
|---|---|---|---|
| Fixed Assets Annual | 111.74 | 126.60 | 141.72 |
| Total Current Assets Annual | 526.39 | 524.22 | 796.10 |
| Non Current Assets Annual | 267.81 | 270.14 | 305.09 |
| Total Shareholders Funds Annual | 536.96 | 538.24 | 750.89 |
| Total Assets Annual | 794.20 | 794.36 | 1,101.19 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 111.74 |
| Total Current Assets Annual | 526.39 |
| Non Current Assets Annual | 267.81 |
| Total Shareholders Funds Annual | 536.96 |
| Total Assets Annual | 794.20 |
No Data Availabe
